These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8711136)

  • 1. Antithrombotic effect of topically applied 3-oxa-methano-prostaglandin I1 in the microcirculation and antiplatelet functions of its active form.
    Nishimura T; Yamamoto S; Yamamoto T; Kaneko M; Hara Y
    Prostaglandins; 1996 Feb; 51(2):149-59. PubMed ID: 8711136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
    Yamamoto T; Satoh K; Nishimura T; Horikawa N; Mine T; Hirohashi T; Hara Y
    Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet functions of a stable prostacyclin analog, SM-10906 are exerted by its inhibitory effect on inositol 1,4,5-trisphosphate production and cytosolic Ca++ increase in rat platelets stimulated by thrombin.
    Nishimura T; Yamamoto T; Komuro Y; Hara Y
    Thromb Res; 1995 Aug; 79(3):307-17. PubMed ID: 8533126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity for [3H]iloprost binding sites and cAMP synthesis activity of a 3-oxa-methano prostaglandin I1 analog, SM-10906, in human platelets and endothelial cells.
    Hiroi T; Maruyama K; Hattori K; Ohnuki T; Nagatomo T; Watanabe K; Yamamoto T; Hara Y
    Jpn J Pharmacol; 1997 May; 74(1):37-43. PubMed ID: 9195295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable prostaglandin I1 analog SM-10906 modulates productions of tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in mouse macrophages.
    Nishimura T; Yamamoto T; Ueda Y; Yamada K; Hara Y
    Biol Pharm Bull; 2000 Jun; 23(6):708-11. PubMed ID: 10864020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic activity of NSP-513, a novel selective phosphodiesterase 3 inhibitor, on femoral arterial thrombosis induced by physical stenosis and electrical current: comparison of antithrombotic and hemodynamic effects.
    Hirose H; Mashiko S; Kimura T; Ishida F; Mochizuki N; Nishibe T; Nishikibe M
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):586-94. PubMed ID: 10774790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mode of action of prostaglandin (PG) I1 analog, SM-10906, on fibroblasts of hypertrophic scars is similar to PGE1 in its potential role of preventing scar formation.
    Zhou LJ; Inoue M; Ono I; Kaneko F
    Exp Dermatol; 1997 Dec; 6(6):314-20. PubMed ID: 9412820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-platelet and anti-thrombotic effects of OP-41483.alpha-CD, a prostacyclin analogue, in experimental animals.
    Katsube N; Sakaguchi K; Fujitani B; Aishita H
    Prostaglandins Leukot Essent Fatty Acids; 1993 Oct; 49(4):795-804. PubMed ID: 8259376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation.
    Sim AK; McCraw AP; Cleland ME; Nishio S; Umetsu T
    Arzneimittelforschung; 1985; 35(12):1816-8. PubMed ID: 3913423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TRK-100, a stable prostacyclin analogue, on regulation of cyclic AMP metabolism in platelets.
    Nogimori K; Kajikawa N; Nishio S; Yajima M
    Prostaglandins; 1989 Feb; 37(2):205-12. PubMed ID: 2543034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent.
    Miller OV; Aiken JW; Shebuski RJ; Gorman RR
    Prostaglandins; 1980 Aug; 20(2):391-400. PubMed ID: 6251513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of a potent, new antithrombotic agent, 1,3-dihydro-7,8-dimethyl-2H-imidazo[4,5-b]quinolin-2-one (BMY-20844).
    Buchanan JO; Fleming JS; Cornish BT; Baryla UM; Gillespie E; Stanton HC; Seiler SM; Keely SL
    Thromb Res; 1989 Nov; 56(3):333-46. PubMed ID: 2559492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
    Kanayama T; Kimura Y; Iseki K; Hayashi Y; Tamao Y; Mizogami S
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1210-7. PubMed ID: 1702154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.
    Fujitani B; Wakitani K
    Jpn J Pharmacol; 1990 May; 53(1):25-33. PubMed ID: 2161965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin I1 analogues, SM-10902 and SM-10906, affect human keratinocytes and fibroblasts in vitro in a manner similar to PGE1: therapeutic potential for wound healing.
    Kaneko F; Zhang JZ; Maruyama K; Nihei Y; Ono I; Iwatsuki K; Yamamoto T
    Arch Dermatol Res; 1995; 287(6):539-45. PubMed ID: 7487139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro and ex vivo antiplatelet effect of TRK-100, a stable prostacyclin analog, in several species.
    Nishio S; Matsuura H; Kanai N; Fukatsu Y; Hirano T; Nishikawa N; Kameoka K; Umetsu T
    Jpn J Pharmacol; 1988 May; 47(1):1-10. PubMed ID: 2842529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prostaglandins and cyclic AMP on cytokine production in rat leukocytes.
    Oh-ishi S; Utsunomiya I; Yamamoto T; Komuro Y; Hara Y
    Eur J Pharmacol; 1996 Apr; 300(3):255-9. PubMed ID: 8739216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhibition of anti-platelet effect of isocarbacyclin methyl ester and its free acid via an increase in cAMP in platelets.
    Aoki Y; Inoue K; Kitahara S; Kiyoki M; Araki H
    Arzneimittelforschung; 1995 Sep; 45(9):970-4. PubMed ID: 7488315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of TFC-612, a 7-thia prostaglandin E1 derivative, on platelet function.
    Motoyama Y; Sakata Y; Seki J; Asada T; Namikawa Y; Horiai H; Ono T
    Thromb Res; 1991 Jul; 63(1):29-38. PubMed ID: 1658963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic effect of SM-20302, a nonpeptide GPIIb/IIIa antagonist, in a photochemically induced thrombosis model in guinea pigs.
    Horisawa S; Kaneko M; Ikeda Y; Ueki Y; Sakurama T
    Thromb Res; 1999 May; 94(4):227-34. PubMed ID: 10336238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.